Ads
related to: solid tumor lung cancer- Dosing & Administration
Healthcare Professionals: See How
Your Patients May Receive Treatment
- Identifying Patients
Discover Patient Identification &
IHC Info. Will You Take Action?
- Access Data & Results
View Data To See If A Treatment For
Metastatic Solid Tumors May Help.
- Official Physician Site
Visit Site For A New Treatment
Option For Metastatic Solid Tumors.
- Request A Contact
Complete A Brief Form To Receive
Updates For A New Treatment Option.
- Approval Info For HCPs
Explore Eligibility Criteria For A
Therapy For Metastatic Solid Tumors
- Dosing & Administration
Search results
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 1 day ago“ADCs form a core part of our differentiated solid tumour pipeline. We have extensive experience and...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 15 hours agoMeanwhile, another study by the Danish biotech firm Evaxion and the Melanoma Institute Australia at...
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
Medical Xpress· 16 hours agoPreliminary data from a Phase I study evaluating the novel antibody-drug conjugate (ADC) M9140 demonstrated encouraging activity in heavily pretreated patients with advanced colorectal
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 22 hours agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
Bushwick biotech raises $7M seed round to advance genetic cancer therapy
Crain's New York Business· 15 hours agoThe seed round, led by LifeSpan Vision Ventures with participation from quadraScope Ventures and other investors, will help Matter Bio move its early-stage injectable cancer
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Pendulum· 3 days agoOlomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.
Team presents promising results from first clinical trial of next-gen antibody in patients with...
Medical Xpress· 16 hours agoThe ongoing trial has already included 104 patients with various types of tumors who had received between one and seven previous courses of treatment. Preliminary results from this phase 1 trial ...
Tumor infiltrating lymphocyte approval heralds new era for precision cancer immunotherapy
Nature· 5 days agoFDA approval of Iovance’s lifileucel for melanoma shows the promise of tumor-infiltrating lymphocytes for the treatment of solid tumors, with trials ongoing ...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 1 day agoQuanqi (125SER) is a marketed human Interleukin-2 used in treating solid tumours including renal...
Molecular Templates reports progress in cancer therapy trials By Investing.com
Investing.com· 20 hours agoMolecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has announced...
